Autologous CD34+ hematopoietic stem cells transduced ex vivo
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous CD34+ hematopoietic stem cells transduced ex vivo, covering 2021-09-20 to 2021-09-20. Get the full timeline:
Most recent: Clinical Trial Update: Autologous CD34+ Hematopoietic Stem Cells Transduced ex Vivo With Elongation Factor 1 Alpha Shortened (EFS) Lentiviral Vector Encoding for the Human ADA Gene [Phase 1, Phase 2]